Table 2 Chi-squared and p-values from pairwise chi-square testing for clinical and demographic categorical characteristics.

From: Clinical correlates of CT imaging-derived phenotypes among lean and overweight patients with hepatic steatosis

 

Lean with steatosis vs Lean without steatosis

Lean with steatosis vs Overweight with steatosis

Lean without steatosis vs Overweight with steatosis

Lean with steatosis vs Overweight without steatosis

Lean without steatosis vs Overweight without steatosis

Overweight with steatosis vs Overweight without steatosis

χ2

p-Value

χ2

p-Value

χ2

p-Value

χ2

p-Value

χ2

p-Value

χ2

p-Value

Sex

6.1

0.017

7.39

9.1E-3

105.8

 < 0.0001

0.42

0.53

57.11

 < 0.0001

23.45

 < 0.0001

Race

9.93

0.024

9.82

0.024

25.23

 < 0.0001

12.63

8.6E-3

92.57

 < 0.0001

18.55

5.8E-4

CVD

23.31

 < 0.0001

2.08

0.17

39.79

 < 0.0001

7.39

9.1E-3

24.02

 < 0.0001

7.01

0.011

HTN

38.26

 < 0.0001

4.93

0.031

280.6

 < 0.0001

0.97

0.34

174.44

 < 0.0001

54.16

 < 0.0001

T2DM

27.35

 < 0.0001

24.21

 < 0.0001

354.8

 < 0.0001

0.08

0.78

105.24

 < 0.0001

159.48

 < 0.0001

HLD

10.4

2.1E-3

7.45

9.1E-3

135.66

 < 0.0001

1.12

0.32

107.41

 < 0.0001

14.58

2.4E-4

  1. p-Values were adjusted with the Benjamini–Hochberg method for a p < 0.05 level of statistical significance. Lean patients have 18.5 kg/m2 ≤ BMI < 25 kg/m2. Patients with steatosis have SHAD ≥  − 1 HU or LMA < 40 HU.
  2. BMI body mass index, SHAD spleen-hepatic attenuation difference, LMA liver mean attenuation, CVD cardiovascular disease, HTN hypertension, T2DM type 2 diabetes mellitus, HLD hyperlipidemia.
  3. Significant values are bold.
Back to article page